TELUS Corporation
TELUS Corporation (TU) Financial Performance & Income Statement Overview
Analyze TELUS Corporation (TU) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
TELUS Corporation (TU) Income Statement & Financial Overview
Explore comprehensive income reports for TELUS Corporation TU, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $5.02B | $5.33B | $5.04B | $4.90B |
| Cost of Revenue | $1.85B | $2.14B | $1.87B | $4.15B |
| Gross Profit | $3.17B | $3.19B | $3.17B | $748.00M |
| Gross Profit Ratio | $0.63 | $0.60 | $0.63 | $0.15 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.47B | $1.48B | $1.48B | $1.47B |
| Operating Expenses | $2.42B | $2.44B | $2.39B | $2.39B |
| Total Costs & Expenses | $4.27B | $4.57B | $4.25B | $4.15B |
| Interest Income | $5.00M | $5.00M | $10.00M | $11.00M |
| Interest Expense | $342.00M | $382.00M | $347.00M | $345.00M |
| Depreciation & Amortization | $992.00M | $1.01B | $968.00M | $971.00M |
| EBITDA | $1.74B | $1.83B | $1.62B | $1.68B |
| EBITDA Ratio | $0.35 | $0.34 | $0.32 | $0.34 |
| Operating Income | $752.00M | $759.00M | $788.00M | $682.00M |
| Operating Income Ratio | $0.15 | $0.14 | $0.16 | $0.14 |
| Other Income/Expenses (Net) | -$344.00M | -$321.00M | -$479.00M | -$382.00M |
| Income Before Tax | $408.00M | $438.00M | $309.00M | $300.00M |
| Income Before Tax Ratio | $0.08 | $0.08 | $0.06 | $0.06 |
| Income Tax Expense | $107.00M | $118.00M | $52.00M | $79.00M |
| Net Income | $321.00M | $358.00M | $280.00M | $228.00M |
| Net Income Ratio | $0.06 | $0.07 | $0.06 | $0.05 |
| EPS | $0.21 | $0.24 | $0.19 | $0.15 |
| Diluted EPS | $0.21 | $0.24 | $0.19 | $0.15 |
| Weighted Avg Shares Outstanding | $1.51B | $1.50B | $1.49B | $1.48B |
| Weighted Avg Shares Outstanding (Diluted) | $1.52B | $1.50B | $1.50B | $1.49B |
The company's financials show resilient growth, with revenue advancing from $4.90B in Q2 2024 to $5.02B in Q1 2025. Gross profit remained healthy with margins at 63% in Q1 2025 compared to 15% in Q2 2024. Operating income hit $752.00M last quarter, sustaining a consistent 15% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $1.74B. Net income dropped to $321.00M, while earnings per share reached $0.21. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan